Relmada Therapeutics Inc.

NASDAQ: RLMD · Real-Time Price · USD
0.73
0.01 (0.70%)
At close: May 29, 2025, 3:59 PM
0.69
-4.60%
Pre-market: May 30, 2025, 07:50 AM EDT

Relmada Therapeutics Revenue

Relmada Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Relmada Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
17
Market Cap
24.08M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.